#clinical trial

Collection of clinical trial news, found 330 news.

PneumRx, Inc. Acquires Key Assets From Broncus

PneumRx, Inc. Acquires Key Assets From Broncus

  • 21st May 2012

-           - Acquisition bolsters PneumRx's position as a leader in ...

PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial

PneumRx, Inc. Receives FDA Approval to Commence Pivotal Clinical Trial

  • 15th May 2012

-Study Results Will be Used to Support PMA Application for the RePneu LVRC System     PneumRx, Inc. ...

Berg Pharma Presents Key Findings In Cancer Systems Biology And Mitochondrial Metabolism

Berg Pharma Presents Key Findings In Cancer Systems Biology And Mitochondrial Metabolism

  • 5th April 2012

-     Berg Pharma, a Boston based pharmaceutical company presented novel data today pertaining to ...

invendo medical Announces 510(k) Clearance by FDA

invendo medical Announces 510(k) Clearance by FDA

  • 27th February 2012

-      - Clearance by FDA makes new endoscope for colon cancer screening available to U.S. ...

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

CAPRELSA(TM) (vandetanib) Receives Positive CHMP Opinion in the European Union

  • 20th November 2011

-         AstraZeneca today announced that the Marketing Authorisation Application ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

  • 26th September 2011

-      March 2011 Data Confirm Strong Treatment Effect of ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

  • 5th September 2011

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

  • 5th September 2011

-        - This release is not intended for US ...

Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore

Inviragen Initiates Phase 1 Study of Hand, Foot and Mouth Disease Vaccine in Singapore

  • 16th June 2011

-         Inviragen announced today the initiation of the first clinical trial of ...

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

Edison Pharmaceuticals to Provide Expanded Access to EPI-743 for Mitochondrial Disease

  • 8th June 2011

-FDA allows use of investigational new drug for life-threatening indications     Edison ...

Wes Wheeler Appointed as CEO by Marken's Board of Directors

Wes Wheeler Appointed as CEO by Marken's Board of Directors

  • 26th May 2011

-        The Marken Board of Directors is pleased to announce the appointment of Wesley ...

Alzheimer`s drug useful in treating heroin addicts

Alzheimer`s drug useful in treating heroin addicts

  • 14th May 2011

Taipei (ANTARA News/CNA) Taiwan`s National Cheng Kung University Hospital (NCKU) and the U.S.`s National Institutes of ...

Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AAC

Cytotech Labs Unravels Hallmark Insight Into Metabolic Control of Cancer, Presents Work at Major AAC

  • 5th April 2011

-        Cytotech Labs, a Boston based pharmaceutical company and member of the Berg ...

QPS Expands Clinical Trial Services with Acquisition of Qualitix

QPS Expands Clinical Trial Services with Acquisition of Qualitix

  • 9th March 2011

-        Broadens later stage capabilities and Increases Asian ...

Marken Announces the Opening of a Directly Owned Clinical Trial Supply

Marken Announces the Opening of a Directly Owned Clinical Trial Supply

  • 8th March 2011

-    Marken, a Leading Life Science Logistics Specialist, has increased presence and capability in ...